BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 34346508)

  • 41. Intronic Cis-Element DR8 in hTERT Is Bound by Splicing Factor SF3B4 and Regulates hTERT Splicing in Non-Small Cell Lung Cancer.
    Slusher AL; Kim JJ; Ribick M; Pollens-Voigt J; Bankhead A; Palmbos PL; Ludlow AT
    Mol Cancer Res; 2022 Oct; 20(10):1574-1588. PubMed ID: 35852380
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lineage-specific splicing of a brain-enriched alternative exon promotes glioblastoma progression.
    Ferrarese R; Harsh GR; Yadav AK; Bug E; Maticzka D; Reichardt W; Dombrowski SM; Miller TE; Masilamani AP; Dai F; Kim H; Hadler M; Scholtens DM; Yu IL; Beck J; Srinivasasainagendra V; Costa F; Baxan N; Pfeifer D; von Elverfeldt D; Backofen R; Weyerbrock A; Duarte CW; He X; Prinz M; Chandler JP; Vogel H; Chakravarti A; Rich JN; Carro MS; Bredel M
    J Clin Invest; 2014 Jul; 124(7):2861-76. PubMed ID: 24865424
    [TBL] [Abstract][Full Text] [Related]  

  • 43. RNA-binding proteins RBM20 and PTBP1 regulate the alternative splicing of FHOD3.
    Lorenzi P; Sangalli A; Fochi S; Dal Molin A; Malerba G; Zipeto D; Romanelli MG
    Int J Biochem Cell Biol; 2019 Jan; 106():74-83. PubMed ID: 30468920
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Large-scale remodeling of a repressed exon ribonucleoprotein to an exon definition complex active for splicing.
    Wongpalee SP; Vashisht A; Sharma S; Chui D; Wohlschlegel JA; Black DL
    Elife; 2016 Nov; 5():. PubMed ID: 27882870
    [TBL] [Abstract][Full Text] [Related]  

  • 45. LPS Administration Impacts Glial Immune Programs by Alternative Splicing.
    Babenko VN; Shishkina GT; Lanshakov DA; Sukhareva EV; Dygalo NN
    Biomolecules; 2022 Feb; 12(2):. PubMed ID: 35204777
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Alternative splicing modulates cancer aggressiveness: role in EMT/metastasis and chemoresistance.
    Roy Burman D; Das S; Das C; Bhattacharya R
    Mol Biol Rep; 2021 Jan; 48(1):897-914. PubMed ID: 33400075
    [TBL] [Abstract][Full Text] [Related]  

  • 47. PTBP1 and PTBP2 Repress Nonconserved Cryptic Exons.
    Ling JP; Chhabra R; Merran JD; Schaughency PM; Wheelan SJ; Corden JL; Wong PC
    Cell Rep; 2016 Sep; 17(1):104-113. PubMed ID: 27681424
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The latest role of nerve-specific splicing factor PTBP1 in the transdifferentiation of glial cells into neurons.
    Chen XD; Liu HL; Li S; Hu KB; Wu QY; Liao P; Wang HY; Long ZY; Lu XM; Wang YT
    Wiley Interdiscip Rev RNA; 2023 Mar; 14(2):e1740. PubMed ID: 35574699
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Emerging Role of the RBM20 and PTBP1 Ribonucleoproteins in Heart Development and Cardiovascular Diseases.
    Fochi S; Lorenzi P; Galasso M; Stefani C; Trabetti E; Zipeto D; Romanelli MG
    Genes (Basel); 2020 Apr; 11(4):. PubMed ID: 32276354
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The alternative splicing of intersectin 1 regulated by PTBP1 promotes human glioma progression.
    Lan C; Zhang H; Wang K; Liu X; Zhao Y; Guo Z; Zhang N; Zhou Y; Gao M; Gu F; Ma Y
    Cell Death Dis; 2022 Sep; 13(9):835. PubMed ID: 36171198
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Unstructured linker regions play a role in the differential splicing activities of paralogous RNA binding proteins PTBP1 and PTBP2.
    Truong A; Barton M; Tran U; Mellody M; Berger D; Madory D; Hitch E; Jibrael B; Nikolaidis N; Luchko T; Keppetipola N
    J Biol Chem; 2024 Mar; 300(3):105733. PubMed ID: 38336291
    [TBL] [Abstract][Full Text] [Related]  

  • 52. PTBP1 acts as a dominant repressor of the aberrant tissue-specific splicing of ISCU in hereditary myopathy with lactic acidosis.
    Rawcliffe DFR; Österman L; Nordin A; Holmberg M
    Mol Genet Genomic Med; 2018 Nov; 6(6):887-897. PubMed ID: 30209894
    [TBL] [Abstract][Full Text] [Related]  

  • 53. PTBP1-Mediated Alternative Splicing Regulates the Inflammatory Secretome and the Pro-tumorigenic Effects of Senescent Cells.
    Georgilis A; Klotz S; Hanley CJ; Herranz N; Weirich B; Morancho B; Leote AC; D'Artista L; Gallage S; Seehawer M; Carroll T; Dharmalingam G; Wee KB; Mellone M; Pombo J; Heide D; Guccione E; Arribas J; Barbosa-Morais NL; Heikenwalder M; Thomas GJ; Zender L; Gil J
    Cancer Cell; 2018 Jul; 34(1):85-102.e9. PubMed ID: 29990503
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification of the role of mono-ADP-ribosylation in colorectal cancer by integrated transcriptome analysis.
    Zhang S; Duan J; Yang Y; Gong H; Tang Y; Xiao M; Li M; Li Q; Wang Y
    Med Oncol; 2021 Aug; 38(9):111. PubMed ID: 34357465
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Specific inhibition of splicing factor activity by decoy RNA oligonucleotides.
    Denichenko P; Mogilevsky M; Cléry A; Welte T; Biran J; Shimshon O; Barnabas GD; Danan-Gotthold M; Kumar S; Yavin E; Levanon EY; Allain FH; Geiger T; Levkowitz G; Karni R
    Nat Commun; 2019 Apr; 10(1):1590. PubMed ID: 30962446
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Splicing Factor PTBP1 Represses
    Taylor W; Deschamps S; Reboutier D; Paillard L; Méreau A; Audic Y
    Cancer Res Commun; 2022 Dec; 2(12):1669-1683. PubMed ID: 36970727
    [TBL] [Abstract][Full Text] [Related]  

  • 57. RBFOX2 modulates a metastatic signature of alternative splicing in pancreatic cancer.
    Jbara A; Lin KT; Stossel C; Siegfried Z; Shqerat H; Amar-Schwartz A; Elyada E; Mogilevsky M; Raitses-Gurevich M; Johnson JL; Yaron TM; Ovadia O; Jang GH; Danan-Gotthold M; Cantley LC; Levanon EY; Gallinger S; Krainer AR; Golan T; Karni R
    Nature; 2023 May; 617(7959):147-153. PubMed ID: 36949200
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Alternative Splicing of
    Li N; Du H; Ren R; Wang Y; Xu Z
    Neural Plast; 2020; 2020():8898811. PubMed ID: 32774357
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A Novel Combination RNAi toward Warburg Effect by Replacement with miR-145 and Silencing of PTBP1 Induces Apoptotic Cell Death in Bladder Cancer Cells.
    Takai T; Yoshikawa Y; Inamoto T; Minami K; Taniguchi K; Sugito N; Kuranaga Y; Shinohara H; Kumazaki M; Tsujino T; Takahara K; Ito Y; Akao Y; Azuma H
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28106737
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Endothelial deletion of PTBP1 disrupts ventricular chamber development.
    Liu H; Duan R; He X; Qi J; Xing T; Wu Y; Zhou L; Wang L; Shao Y; Zhang F; Zhou H; Gu X; Lin B; Liu Y; Wang Y; Liu Y; Li L; Liang D; Chen YH
    Nat Commun; 2023 Mar; 14(1):1796. PubMed ID: 37002228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.